The GLP 1 Dilemma: Weighing Benefits and Risks in Pediatric Treatment The increasing use of GLP 1 drugs among children and teens has sparked a necessary conversation about their long term effects, efficacy, and potential risks.
While these medications have shown promise in addressing obesity and type 2 diabetes in adults, the pediatric population raises unique concerns that demand careful consideration.
Research suggests that GLP 1 prescriptions for children under 12 are on the rise, with a significant jump in usage over the past few years. A recent study found that nearly 0.